Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases (Q44389295)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases |
scientific article published in April 2003 |
Statements
1 reference
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases (English)
1 reference
Hagop M Kantarjian
1 reference
Guillermo Garcia-Manero
1 reference
Maurizio Zangari
1 reference
Maher Albitar
1 reference
Francis J Giles
1 reference
Jeffrey E Lancet
1 reference
Alison L Hannah
1 reference
Alison T Stopeck
1 reference
Lewis Silverman
1 reference
Julie M Cherrington
1 reference
Judith E Karp
1 reference
Maureen A Cooper
1 reference
Paul J Shami
1 reference
Khuda D Khan
1 reference
Deborah A Thomas
1 reference
1 April 2003
1 reference
Identifiers
1 reference